Evidence map›Paper›PMID 33795997›Full record

ArticleDose-response : a publication of International Hormesis Society

In Vitro Antioxidant Activities and the Therapeutic Potential of Some Newly Synthesized Chalcones Against 4-Acetaminophenol Induced Hepatotoxicity in Rats.

Muhammad Shoaib Akhtar, Aziz-Ur- Rehman, Haroon Arshad, Abdul Malik, Muheer Fatima, Tahira Tabassum, Abdul Rauf Raza, Munnaza Bukhsh, Mian Anjum Murtaza, Malik Hassan Mehmood and 3 more

Open access · goldAbstract read
In one paragraph

Article in Dose-response : a publication of International Hormesis Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Muhammad Shoaib AkhtarDepartment of Pharmacology, College of Pharmacy, University of Sargodha, Sargodha, Pakistan.
Aziz-Ur- RehmanDepartment of Pathobiology, College of Veterinary and Animal Sciences (Jhang Campus), University of Veterinary and Animal Sciences, Lahore, Pakistan.
Haroon ArshadHealth Department, Government of the Punjab, Lahore, Pakistan.
Abdul MalikDepartment of Pharmacology, College of Pharmacy, University of Sargodha, Sargodha, Pakistan.
Muheer FatimaDepartment of Pharmacology, College of Pharmacy, University of Sargodha, Sargodha, Pakistan.
Tahira TabassumDepartment of Pathology, Sargodha Medical College, University of Sargodha, Sargodha, Pakistan.
Abdul Rauf RazaIbn-e-Sina Block, Department of Chemistry, University of Sargodha, Sargodha, Pakistan.
Munnaza BukhshFoundation University Medical College, Islamabad, Pakistan.
Mian Anjum MurtazaInstitute of Food Science and Nutrition, University of Sargodha, Sargodha, Pakistan.
Malik Hassan MehmoodDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad, Pakistan.
Ayesha SultanDepartment of Chemistry, University of Education, Faisalabad Campus, Faisalabad, Pakistan.
Ghulam RasoolDepartment of Allied Health Sciences, Sargodha Medical College, University of Sargodha, Sargodha, Pakistan.
Muhammad RiazDepartment of Allied Health Sciences, Sargodha Medical College, University of Sargodha, Sargodha, Pakistan.ORCID https://orcid.org/0000-0002-5524-7735
University of Sargodha · PKFoundation University Medical College · PKGovernment College University, Faisalabad · PKGovernment of Pakistan · PKUniversity of Faisalabad · PKUniversity of Veterinary and Animal Sciences · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The lack of safety and efficacy of existing hepatoprotective agents urge the need to explore novel hepatoprotective agents. The research work was planned to study the therapeutic potential of some newly synthesized chalcones against 4-acetaminophenol induced hepatotoxicity in rats. Male albino rats (N = 30) were divided into 6 groups of 5 animals each i.e. group I; Toxic control (4-acetaminophenol), group II; normal control (Normal saline), group III; Positive control (silymarin; 50 mg/kg bw) and groups IV-VI (test groups) treated with 3 chalcone analogues i-e 3a, 3f & 3 g (100, 150, 150 mg/kg bw, respectively). All the study group animals were administered with 4-acetaminophenol to induce hepatotoxicity except normal control. Following hepatotoxicity induction, test group animals were administered with selected doses of test compounds and toxic group animals left untreated. Liver enzymes including ALT, AST, ALP and serum bilirubin were determined photometrically. Antioxidant activities of test compounds were also determined. Histopathological examination of liver biopsies was also carried out through H & E staining. The test chalcones (

Indexed as

4-acetaminophenolantioxidantchalconeshepatoprotectivehistologyliver enzymes

Identifiers

PMID33795997
PMCPMC7968038
OpenAlexW3138187602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.